Theme: Conceptual Applications to encounter the Infectious Diseases
Influenza Research 2019
3rd International Conference on Influenza and Emerging Infectious Diseases is a unique international platform for Researchers, Young Scholars, Ecologists, Physicians, Consultants, Diagnostic Specialists, Practice Nurses, Students, Academicians, Pioneers including Clinical and Medical professionals from various fields: Microbiology, Virology, Immunology, Oncology, Ecology, Evolution, Community Health, Public Health, Hospital Health, Industries (Pharmaceutical, Vaccines, drugs, antimicrobials) and etc., to exchange the technical and conceptual knowledge need to encounter the infectious diseases and illness might be Food Borne, Water Borne, Air Borne, and etc. are cause of public health crises such as Crimean-Congo haemorrhagic fever (CCHF), Ebola virus disease, Marburg virus disease, Lassa fever, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome (SARS), Nipah, henipaviral diseases, Rift Valley fever (RVF), Zika, HIV, AIDS and etc.
Being witnessed the triumph of Flu 2016,Organising Committee Members are delighted to announce the next event 3rdInternational Conference on Influenza & Emerging Infectious DiseasesduringApril 10-11, 2019inToronto, Canada.
This Unique international platform also facilitates
- New research findings and scientific books can be released.
- Collaboratewith universities, labs, research centers, industries and etc.
- Promotionfor your own labs will be feasible.
- Provides a platform to organize symposia or workshops
- Special interactive sessions will be provided.
The field ofInfectious Diseases is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.
Selected contributions will be published in following Journals
Details of Influenza Conferences in 2019 in the USA:
Conference Name | Place | Date |
---|---|---|
Influenza Conference 2019 | Toronto , Ontario , Canada | April 10-11, 2019 |
Diversified technical sessions allow to meet the accomplished people are delivering their tremendous research presentations based on the theme "Conceptual Applications to encounter the Infectious Diseases"
CONFERENCE HIGHLIGHTS
- Influenza & Infectious Diseases
- Fungal Infectious Diseases
- Infectious Disease Epidemiology
- Clinical Infectious Diseases
- Pathological Studies
- Bacterial Infectious Diseases
- Antimicrobial Resistance and Infectious Diseases
- Viral Infectious Diseases
- Cancer & infections
- Hospital (Healthcare) Acquired Infectious Diseases
- Pediatric Infectious Diseases
- Gastrointestinal Infectious Diseases
- Diagnosis and Treatment for Infectious Diseases
- Sexually Transmitted Infectious Diseases
- Neurological Infectious Diseases
- Dermatological Infectious Diseases
- Pulmonary Infectious Diseases
- Ophthalmological Infectious Diseases
- Zoonotic Diseases
- Antigenic Variation of Flu/ Influenza Virus
- Public Health Research
- Case studies on Infectious Diseases
- Treatment for Infectious Diseases
- Coinfection: Multi Pathogen Infectious Diseases
- Non Communicable Diseases (NCDs)
- Foodborne Illness Infectious Diseases
- Nutritional Supplements and Herbal Medicines
- Rion Infectious Diseases
- Emerging Protozoan Pathogens Infectious Diseases
Related Conferences:
5th Annual Congress on Rare Diseases and Orphan Drugs, August 29-30, 2018 Boston, USA, 5th International Conference on Neglected Tropical & Infectious Diseases, August 29-30, 2018 Boston, USA, 4th International Conference on Infection, Disease Control & Prevention, May 17-18, 2019 Philadelphia, Pennsylvania, USA, 4th Annual Congress on Infectious Diseases, August 29-30, 2018 Boston, USA, 7th International Conference and exhibition on Bacteriology & Antibiotics, April 24-25, 2019 Vancouver, Canada
11th International Conference on Rare Diseases and Orphan Drugs (ICORD), September 13-16, 2018 Johannesburg, South Africa; Orphan Drugs Summit, September 2018, The Netherlands; SMi's 7th annual Orphan Drugs and Rare Diseases UK Conference, 18–19 October 2017 London, United Kingdom
Related Societies:
USA: AIDS Healthcare Foundation, Centre for AIDS Research, Northland Cares, Arizona, The McGregor Clinic, Inc., Canadian Public Health Association, Tropical Pathology & Infectious Diseases Associations, International Society for Infectious Diseases, AIDS United, HIV.gov, AmfAR, UNAIDS, The Elizabeth Taylor AIDS Foundation, International AIDS Society, International HIV/AIDS Alliance, Addiction Research and Treatment Corporation, AIDS Community Research Initiative of America, Albert Einstein College of Medicine, Community Healthcare Network, Elmhurst Hospital Center, Evergreen AIDS Foundation, Lifelong AIDS Alliance
Europe: European Society for Clinical Microbiology and Infectious Diseases, British Society for Antimicrobial Chemotherapy, Society for General Microbiology
Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.
Infectious Disease Therapeutics Market (drugs & vaccine) was valued at US$ 105.13 Billion in 2018 and expected to reach USD 179.70 Billion by the end of 2025 with a growing potential of 7.96 %.
Top 6 Infectious Diseases (HIV, malaria, hepatitis, influenza, Human Papillomavirus (HPV), and tuberculosis) therapeutics market worth $86.2 Billion By 2025
The global Influenza therapeutics market was valued USD 1699.7 Million in 2016, and is estimated to reach US$ 2012.6 Million by 2025, with a growth potential of 1.4%
Major factors those are driving the growth of the market:
- Increasing the occurrence of infectious diseases
- Growing use of direct acting anti-viral
- Increasing healthcare expenditure
- Increasing geriatric population,
- Growing healthcare awareness
- Increasing government funding’s in developing countries.
- The major factor restraining the growth of the market is generic erosion, Patent expiration of infectious disease drugs.
Regional wise Infectious disease Therapeutics Market
- North America: USA & Canada
- Europe: Germany, UK, France, Spain, Italy, Nordic countries, Benelux, Poland & Russia
- Asia Pacific: China, India, Japan, ASEAN, Australia, and New Zealand
- Latin America: Brazil & Mexico
- Middle East & Africa: GCC, Southern Africa, North Africa
Therapeutics
- Anti-infective drugs: Antibacterial, antifungal, antiparasitic, and antiviral drugs are some of the anti-infective drugs used for the treatment of infectious diseases.
- Vaccines
End users:
- Pediatrics
- Adolescence
- Adults
- Elderly
Disease type therapeutics market
HIV
- Emtriva
- Aptivus
- Isentress
- Lexiva/Telzir
- Selzentry
- Tivicay
- Atripla
- Complera
- Genvoya
- Odefsey
- Stribild
- Truvada
- Triumeq
- Descovy
- Vitekta
Influenza
- Relenza
- Tamiflu
- Rapivab
TB
- Sirturo
Malaria
- Coartem
HPV
Hepatitis
Key Players of Infectious disease Therapeutics Market
- Abbott Laboratories
- AbbVie, Astellas Pharma
- Achillion Pharmaceuticals
- Astrazeneca PLC
- AstraZeneca, Auritec Pharmaceuticals
- Bayer
- Biocryst Pharmaceuticals Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb
- Chimerix Pharmaceuticals
- Chiron Corporation
- CSL Limited
- Cubist, Eli Lilly
- Daiichi Sankyo Co. Ltd.
- F. Hoffmann-La Roche AG
- Gilead Sciences
- Gilead Sciences, Inc.
- Glaxosmithkline PLC
- Isis Pharmaceuticals
- Janssen Pharmaceutical
- Johnson & Johnson
- Pfizer
- Merck & Co., Inc.
- Mitsubishi Tanabe Pharma Corporation
- Nanotherapeutics Inc.
- Novartis International AG
- Protein Sciences Corporation
- pSivida
- Roche Holding AG
- Sanofi SA
- Shionogi & Co. Ltd.
- Sinovac Biotech Ltd.
Reference:
- Centers for Disease Controle and Prevention
- National Institute of Allergy and Infectious Diseases
- Infectious Diseases Society of America
- Business Wire
- Research and Markets
- Future Market Insights
- Credence Research
- Yahoo finance
- Industry Experts Inc.
- BCC Research
- PR Newswire Association LLC
- Report Buyer
- Market Data Forecast
- Grand View Research, Inc.
- Transparency Market Research
- Persistence Market Research
- Coherent Market Insights
- Influenza Research Database
- Influenza Reagent Resource
- BEI Resources
- ATCC
Issue with VISA!!
Are you planning to have a professional and delightful trip to Toronto, Canada???
We believe you must be having a query regarding your Visa to Visit as a Speaker/Delegate, Tourist or Business Person at Toronto, Canada. Influenza Research Committee will be happy to help you in all regards to plan your trip to Toronto, Canada. Here is the simplest way to know the process for your Visa Approval. Kindly drop us an email at
Conference Highlights
- Influenza Research
- Infectious Disease Epidemiology
- Clinical Infectious Diseases
- Antimicrobial Resistance and Infectious Diseases
- Pathological Studies
- Treatment for Infectious Diseases
- Fungal Infectious Diseases
- Bacterial Infectious Diseases
- Neurological Infectious Diseases
- Zoonotic Diseases
- Cancer & infections
- Rion Infectious Diseases
- Gastrointestinal Infectious Diseases
- Case studies on Infectious Diseases
- Diagnosis and Treatment for Infectious Diseases
- Hospital (Healthcare) Acquired Infectious Diseases
- Sexually Transmitted Infectious Diseases
- Pediatric Infectious Diseases
- Dermatological Infectious Diseases
- Pulmonary Infectious Diseases
- Ophthalmological Infectious Diseases
- Nutritional Supplements and Herbal Medicines
- Public Health Research
- Foodborne Illness Infectious Diseases
- Non Communicable Diseases (NCDs)
- Antigenic Variation of Flu/ Influenza Virus
- Viral Infectious Diseases
- Emerging Protozoan Pathogens Infectious Diseases
- Coinfection: Multi Pathogen Infectious Diseases
- Immunology Antibodies
- Vaccine Research & Development
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | April 10-11, 2019 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by